These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 21749780

  • 1. High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia.
    Aguado JM, San-Juan R, Lalueza A, Sanz F, Rodríguez-Otero J, Gómez-Gonzalez C, Chaves F.
    Emerg Infect Dis; 2011 Jun; 17(6):1099-102. PubMed ID: 21749780
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
    [Abstract] [Full Text] [Related]

  • 4. Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.
    Song KH, Kim M, Kim CJ, Cho JE, Choi YJ, Park JS, Ahn S, Jang HC, Park KH, Jung SI, Yoon N, Kim DM, Hwang JH, Lee CS, Lee JH, Kwak YG, Kim ES, Park SY, Park Y, Lee KS, Lee YS, Kim HB.
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956430
    [Abstract] [Full Text] [Related]

  • 5. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
    Mascitti KB, Edelstein PH, Fishman NO, Morales KH, Baltus AJ, Lautenbach E.
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):160-6. PubMed ID: 22227985
    [Abstract] [Full Text] [Related]

  • 6. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
    Panesso D, Planet PJ, Diaz L, Hugonnet JE, Tran TT, Narechania A, Munita JM, Rincon S, Carvajal LP, Reyes J, Londoño A, Smith H, Sebra R, Deikus G, Weinstock GM, Murray BE, Rossi F, Arthur M, Arias CA.
    Emerg Infect Dis; 2015 Oct; 21(10):1844-8. PubMed ID: 26402569
    [Abstract] [Full Text] [Related]

  • 7. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
    Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB.
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):181-5. PubMed ID: 16505987
    [Abstract] [Full Text] [Related]

  • 8. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
    Wong D, Wong T, Romney M, Leung V.
    BMC Infect Dis; 2016 May 23; 16():224. PubMed ID: 27215201
    [Abstract] [Full Text] [Related]

  • 9. Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Lee HY, Chen CL, Liu SY, Yan YS, Chang CJ, Chiu CH.
    PLoS One; 2015 May 23; 10(8):e0136171. PubMed ID: 26295150
    [Abstract] [Full Text] [Related]

  • 10. No effect of vancomycin MIC ≥ 1.5 mg/L on treatment outcome in methicillin-susceptible Staphylococcus aureus bacteraemia.
    Bouiller K, Laborde C, Aho SL, Hocquet D, Pechinot A, Le Moing V, Bertrand X, Piroth L, Chirouze C.
    Int J Antimicrob Agents; 2018 May 23; 51(5):721-726. PubMed ID: 29305961
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of Vancomycin plus a β-Lactam versus Vancomycin Only for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Truong J, Veillette JJ, Forland SC.
    Antimicrob Agents Chemother; 2018 Feb 23; 62(2):. PubMed ID: 29133561
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
    Cervera C, Castañeda X, de la Maria CG, del Rio A, Moreno A, Soy D, Pericas JM, Falces C, Armero Y, Almela M, Ninot S, Pare JC, Mestres CA, Gatell JM, Marco F, Miro JM, Hospital Clinic Endocarditis Study Group.
    Clin Infect Dis; 2014 Jun 23; 58(12):1668-75. PubMed ID: 24647021
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia.
    Wong D, Wong T, Romney M, Leung V.
    Ann Clin Microbiol Antimicrob; 2016 Apr 26; 15():27. PubMed ID: 27112143
    [Abstract] [Full Text] [Related]

  • 17. Vancomycin minimum inhibitory concentration, host comorbidities and mortality in Staphylococcus aureus bacteraemia.
    Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV, Anderson TL, Roberts SA, Warren SJ, Gao W, Johnson PD, Howden BP.
    Clin Microbiol Infect; 2013 Dec 26; 19(12):1163-8. PubMed ID: 23441652
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.